A Phase 1 SBIR Grant from NINDS was Received by Extend Biosciences
The grant will be used to fund proof-of-concept work and efficacy studies on a long-acting ghrelin for the treatment of peripheral neuropathy.
The grant will be used to fund proof-of-concept work and efficacy studies on a long-acting ghrelin for the treatment of peripheral neuropathy.